Yahoo
NYSE American - Delayed Quote USD

China Pharma Holdings, Inc. (CPHI)

0.6249 -0.0251 (-3.86%)
At close: 4:00:00 PM EDT
0.6102 -0.0147 (-2.35%)
After hours: 5:26:30 PM EDT
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
3,914.0900
4,144.2680
4,528.9290
7,011.2990
8,104.0920
Cost of Revenue
3,453.9160
4,276.2180
6,514.5770
7,292.3840
8,598.0080
Gross Profit
460.1740
-131.9500
-1,985.6480
-281.0850
-493.9160
Operating Expense
4,837.7750
2,956.5900
2,597.5160
2,486.4920
3,148.9120
Operating Income
-4,377.6010
-3,088.5400
-4,583.1640
-2,767.5770
-3,642.8280
Net Non Operating Interest Income Expense
-98.3050
-100.0340
-147.4990
-326.9980
-423.8640
Other Income Expense
--
1.0180
-5.7020
15.7570
93.8510
Pretax Income
-4,474.8880
-3,187.5560
-4,736.3650
-3,078.8180
-3,972.8410
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-4,474.8880
-3,187.5560
-4,736.3650
-3,078.8180
-3,972.8410
Diluted NI Available to Com Stockholders
-4,474.8880
-3,187.5560
-4,736.3650
-3,078.8180
-3,972.8410
Basic EPS
-0.42
-0.74
-2.71
-9.10
-37.80
Diluted EPS
-0.42
-0.74
-2.71
-9.10
-37.80
Basic Average Shares
19,704.3230
4,291.4270
1,746.3720
338.3570
105.1370
Diluted Average Shares
19,704.3230
4,291.4270
1,746.3720
338.3570
105.1370
Total Operating Income as Reported
-4,377.4490
-3,239.0780
-4,588.8660
-2,751.8200
-3,548.9770
Total Expenses
8,291.6910
7,232.8080
9,112.0930
9,778.8760
11,746.9200
Net Income from Continuing & Discontinued Operation
-4,474.8880
-3,187.5560
-4,736.3650
-3,078.8180
-3,972.8410
Normalized Income
-4,475.9060
-3,188.5740
-4,730.6630
-3,094.5750
-4,066.6920
Interest Income
0.7350
2.0030
6.6410
6.6020
10.7550
Interest Expense
99.0400
102.0370
154.1400
333.6000
434.6190
Net Interest Income
-98.3050
-100.0340
-147.4990
-326.9980
-423.8640
EBIT
-4,375.8480
-3,085.5190
-4,582.2250
-2,745.2180
-3,538.2220
EBITDA
-1,323.4610
-1,506.3500
-1,905.2280
8.4350
-837.6890
Reconciled Cost of Revenue
3,453.9160
4,276.2180
6,514.5770
7,292.3840
8,598.0080
Reconciled Depreciation
3,052.3870
1,579.1690
2,676.9970
2,753.6530
2,700.5330
Net Income from Continuing Operation Net Minority Interest
-4,474.8880
-3,187.5560
-4,736.3650
-3,078.8180
-3,972.8410
Total Unusual Items Excluding Goodwill
1.0180
1.0180
-5.7020
15.7570
93.8510
Total Unusual Items
1.0180
1.0180
-5.7020
15.7570
93.8510
Normalized EBITDA
-1,324.4790
-1,507.3680
-1,899.5260
-7.3220
-931.5400
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 4/17/2002

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: